Literature DB >> 1740964

Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock.

P Vadas1, K Scott, G Smith, I Rajkovic, E Stefanski, B D Schouten, R Singh, W Pruzanski.   

Abstract

Massive elevations of serum phospholipase A2 activity have been documented in patients with septic shock. Serum PLA2 activity correlated to the degree and duration of circulatory collapse, while purified native PLA2 reproduced hypotension in experimental animals. In a prospective study of patients with septic shock, we have determined the relationship of PLA2 enzyme activity to PLA2 immunoreactivity using radiolabelled E. coli phospholipid substrate and an ELISA specific for group II human nonpancreatic PLA2. In all patients, there was a clear concordance of the two assays. Maximal PLA2 concentration was increased a mean of 554-fold over normal levels. We found no evidence to support the presence of activating or inhibitory proteins. These data confirm that the observed increase in serum PLA2 activity in septic shock is due to intravascular release of group II nonpancreatic PLA2.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740964     DOI: 10.1016/0024-3205(92)90186-s

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

1.  Secretory non-pancreatic phopholipase A2 in severe sepsis: relation to endotoxin, cytokines and thromboxane B2.

Authors:  B Guidet; O Piot; J Masliah; V Barakett; E Maury; G Bereziat; G Offenstadt
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

2.  Zinc (Zn2+) binds to and stimulates the activity of group I but not group II phospholipase A2.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

3.  Interleukin-6 changes tight junction permeability and intracellular phospholipid content in a human enterocyte cell culture model.

Authors:  Y Tazuke; R A Drongowski; D H Teitelbaum; A G Coran
Journal:  Pediatr Surg Int       Date:  2003-05-06       Impact factor: 1.827

4.  Effects of endotoxin and dexamethasone on group I and II phospholipase A2 in rat ileum and stomach.

Authors:  I Lilja; J Dimberg; R Sjödahl; C Tagesson; C Gustafson-Svärd
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

5.  Selective inhibition of group II phospholipase A2 by quercetin.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

6.  Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

7.  Flavonoids as phospholipase A2 inhibitors: importance of their structure for selective inhibition of group II phospholipase A2.

Authors:  M Lindahl; C Tagesson
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

8.  Phospholipase A(2) activates hemostasis.

Authors:  Thomas W Stief
Journal:  Drug Target Insights       Date:  2007-03-22

9.  Quantitation of human tissue and immune cell type II 14 kDa phospholipase A(2) by enzyme immunoassay.

Authors:  B J Bolognese; S D Holmes; L J McMillan; K F Kaiser; L A Marshall
Journal:  Inflammopharmacology       Date:  1997       Impact factor: 5.093

10.  Group II phospholipase A(2) in human gingiva with periodontal disease.

Authors:  H Shinohara; T Komatsubara; H Tojo; M Okamoto; S Nishikawa; T Nagata; H Ishida
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.